Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Null

Last content change checked dailysee data sync status

Active ingredient
albumin (human) 0.25
Other brand names
Dosage form
Injection
Route
Intravenous
Prescription status
Rx (prescription)
Marketed in the U.S.
Since 2079
Active ingredient
albumin (human) 0.25
Other brand names
Dosage form
Injection
Route
Intravenous
Prescription status
Rx (prescription)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2079
Manufacturer
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service
Registration number
BLA101993
Biosimilarity information
Biosimilarity information

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Biosimilarity

Null is the FDA‑licensed reference product against which biosimilar and interchangeable products are compared.

Product PresentationBiosimilarity Status
Multi-Dose Vial0.25
    discontinued
    0.25
      Reference product

        Biosimilarity

        Null is the FDA‑licensed reference product against which biosimilar and interchangeable products are compared.

        Product PresentationBiosimilarity Status
        Multi-Dose Vial0.25
          discontinued
          0.25
            Reference product
              Data Generation & Sources

              This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Null, retrieved by a validated AI data-extraction workflow.

              All FDA-licensed dosage forms and strengths are listed in the Packaging & NDC Codes section above. Biosimilarity and interchangeability details appear in the Biosimilarity Information section above. Regulatory status and reference/interchangeability data were cross-checked against the FDA Purple Book (BLA101993) and the NSDE NDC Directory daily file.

              Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

              No human clinician has reviewed this version.

              Learn more in our Editorial Policy

              Last AI update:

              Primary FDA sources:

              Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

              Purple Book data shown on this page are limited to biosimilarity status — specifically, whether a product is designated as a Biosimilar, Interchangeable, or the Reference Product. For biosimilars and interchangeable biologics, the corresponding reference product information is also sourced directly from the FDA Purple Book.

              Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

              Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.